Table of Contents
Big pharma often plays “fund, license, kill” - a strategy which requires extreme precision in an industry where missing a competitor or hallucinating a patent number is a never-event.
OPTIC is building an agentic AI platform for biopharma that:
- ingests everything that matters, from FDA filings and patents to internal strategy documents
- maps competitive landscapes, evaluates assets, and informs both regulatory and commercial decisions
- uses a multi-agent system designed to avoid hallucination
The result: decisions delivered ~10× faster and ~5× cheaper than traditional approaches.
Onyx caught up with CEO Andrey Doronichev at JPM 2026 to find out more.
A special thanks to our Onyx Live sponsors:
HUMPHREYS LAW - a focused, full-service law firm advising clients in the technology and media sectors. https://humphreys.law/
Panacea - AI-powered FDA consultants. File your IND in half the time. https://withpanacea.com/
I hope you enjoy watching!
Yours sincerely,
Dr. Adil Ali
Comments